S&P 500 7,591.70 −0.58%
Nasdaq 26,081.73 −0.65%
S&P/TSX 35,506.28 −1.11%
Apple 326.57 +3.56%
Nvidia 218.36 −2.37%
Microsoft 492.44 +0.16%
Shopify 175.14 +0.01%
Royal Bank 284.98 −0.21%
CAD/USD 0.7225 −0.26%
CLOSED · 02:10 ET
Market ClerkRecap
Fri Sep 11 · markets closed4 signals on Sep 10223 insider buys this week · $359.5MCIRO short report next: Sep 14The week ahead

CRIS

CURIS INC
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
1.16
−0.04 −3.33%
USD · close Sep 10

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $2.4MP/E DIV YIELD FCF YIELD REV TTM $4.3M −62.2%NET INCOME −$21.2MNET CASH $4.2M52W 1.16 – 36.40SEC XBRL · TTM TO Invalid Date

Financials

SEC XBRL · 62 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q2 2026 · Jun 30$0−100.0%−$9.9M−$8.6M-4.02−$9.6MAug 14
Q1 2026 · Mar 31$0−100.0%−$11.5M−$24.2M-1.25−$9MAug 14
Q4 2025 · Dec 31derived$1.1M−66.0%$19.6M$19.4M1.61−$6.4MMar 24
Q3 2025 · Sep 30$3.2M+8.4%−$6.9M−$7.7M-0.49−$5.6MNov 6
Q2 2025 · Jun 30$2.7M+8.0%−$8.3M−$8.6M-13.61−$8MAug 14
Q1 2025 · Mar 31$2.4M+14.1%−$10.2M−$10.6M-1.25−$7.3MAug 14
Q4 2024 · Dec 31derived$3.3M+24.1%−$9M−$9.6M-1.11−$9.3MMar 24
Q3 2024 · Sep 30$2.9M+3.5%−$10.6M−$10.1M-1.70−$5.9MNov 6
Q2 2024 · Jun 30$2.5M−$12.5M−$11.8M-2.03−$11.1MNov 6
Q1 2024 · Mar 31$2.1M−$12.5M−$11.9M-2.05−$13.2MNov 6
Q4 2023 · Dec 31derived$2.7M−$12.2M−$11.7M-2.00−$10.2M$0−$10.2MMar 31
Q3 2023 · Sep 30$2.8M−$12.4M−$12.2M-2.13−$8.2M$0−$8.2MNov 14

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2025 · to Dec 31$9.4M−$5.7M−$7.6M-80.3%-0.58−$27.2M
FY2024 · to Dec 31$10.9M−$44.5M−$43.4M-397.8%-6.88−$39.6M
FY2023 · to Dec 31$10M−$48.3M−$47.4M-473.0%-8.96−$38.4M$0−$38.4M
FY2022 · to Dec 31$10.2M−$53M−$56.7M-557.7%-12.14−$54.3M$416K−$54.8M
FY2021 · to Dec 31$10.6M−$42.1M−$45.4M-426.7%0.50−$37.6M$0−$37.6M
FY2020 · to Dec 31$10.8M−$24.9M−$29.9M-276.0%-0.61−$25.7M$677K−$26.4M

Every number comes from CURIS INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch CRIS. Know when insiders buy.
One email the day a filing lands. Free.